Jiabiyou (688089.SH) stated on the interactive platform on November 19th that the company uses synthetic biology as the underlying technology, cell factory as the preparation method, and sustainable biomanufacturing to provide high-quality nutrient products and innovative solutions for global nutrition and health customers. Currently, the main products include polyunsaturated fatty acids class ARAs, algae oil DHAs, terpenes beta-carotene, astaxanthin, saccharides SAs, and HMOs, which are widely used in the fields of infant formula milk powder, large health food, animal nutrition, personal care, and beauty, and based on the characteristics of synthetic biology underlying technology, expand to the fields of biomedicine, biomaterials, biotechnology, etc., temporarily not involved in NMN (nicotinamide mononucleotide) related technology and research and development.
嘉必优(688089.SH):暂未涉及NMN相关技术和研发
cabio biotech(wuhan) (688089.SH): has not yet involved in NMN related technology and research
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.